FDA Approves Key Brain Implant for Paralyzed Patients
Summary
In a groundbreaking development, the FDA has approved a key component of Precision Neuroscience's brain implant system, paving the way for paralyzed patients to potentially regain speech and movement through a cutting-edge brain-computer interface technology that rivals efforts by Neuralink, Synchron, and other prominent players.
Key Points
- Precision Neuroscience announced that a core component of its brain implant system has been approved by the FDA
- The company is building a brain-computer interface to help paralyzed patients restore functions like speech and movement
- Other prominent startups in the brain-computer interface space include Elon Musk's Neuralink and Synchron, backed by Jeff Bezos and Bill Gates